Loading organizations...
BEVC operates as an early-stage venture capital firm, specializing in transforming scientific breakthroughs into viable companies. The firm provides capital and deep technical, strategic, and operational support to founders pursuing transformational technologies. Their investment focus spans critical frontiers, including biology, health, artificial intelligence, and deep tech, from molecules to new materials.
The firm was founded by a collective of experienced investors, scientists, and company builders, leveraging diverse backgrounds in startups, academia, and capital markets. This team recognized the potential in bridging groundbreaking academic research with commercial application. They aim to advance science for societal benefit, guiding emerging ventures through growth challenges.
BEVC primarily serves pioneering technical entrepreneurs emerging from world-class research institutions, particularly within the Berkeley and UCSF ecosystems. The firm's long-term vision centers on cultivating a portfolio of scalable, defensible businesses that convert bold scientific ideas into thriving enterprises, ultimately creating market impact.
BEVC has 2 tracked investments across 2 companies. The latest tracked deal is $13.0M Seed in Radar Therapeutics in May 2024.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 1, 2024 | Radar Therapeutics | $13.0M Seed | — | Angelic Ventures, Arizona Tech Investors, B Capital Group, Endeavor Venture Funds, ExSight Capital Management, IVP, NFX, Pioneer Fund, Prithvi Ventures, Chris Gibson, Biovision Ventures, ELI Lilly And Company, KDT Ventures, Pear VC |
| Feb 1, 2024 | Insamo | $12.0M Seed | — | Eclipse Ventures, Playground Global, VenBio Partners, Kyle York, Axial VC, Civilization Ventures, MRL Ventures Fund, Sahsen Ventures |